Imogen Mansfield

Imogen Mansfield is currently serving as Vice President of Biotech Equity Research at Cantor Fitzgerald since September 2023, working with Josh Schimmer and Eric Schmidt. Prior experience includes roles as Senior Life Sciences Consultant and Life Sciences Consultant at L.E.K. Consulting from October 2021 to September 2023. Imogen has also held the position of Case Writing Fellow at Stanford University's Graduate School of Business from August 2020 to September 2021 and has experience in business development at Cambridge Cancer Genomics in early 2018. Previous positions at GSK spanned from September 2014 to August 2017, including Manager in the Oncology Cell Therapy Group and participation in the Management Future Leaders Program. Additional roles include Associate at SR One, intern positions at GSK and Horizon Discovery, and early research experience at Karolinska Institutet and Harbin Institute of Technology. Imogen holds an MBA from Stanford University and both an MA and BA in Natural Sciences (Genetics) from the University of Cambridge.